Author

Hilary Calvert

Observed names: A CALVERT, A Calvert, A H Calvert, A Hilary Calvert, A. Calvert, A. H. CALVERT, A. H. Calvert, A. Hilary Calvert, A.H Calvert, A.H. Calvert, A.Hilary Calvert, AH Calvert, Alan Calvert, Alan Hilary Calvert, CALVERT, A, CALVERT, H, Calvert, A. H., Calvert, A.H., Calvert, H, Calvert, Hilary, H CALVERT, H Calvert, H. Calvert, H.A Calvert, Hilary A. Calvert, Hilary Allan Calvert
Observed institutions: Human Genome Sciences (United States), National Health Service, Queen's University Belfast, Novartis (Switzerland), Fox Chase Cancer Center, BC Cancer Agency, Pennsylvania State University, American Society of Clinical Oncology, Royal Marsden NHS Foundation Trust, Mayo Clinic, Boehringer Ingelheim (Germany), University College London Hospitals NHS Foundation Trust, University of Trieste, Institute of Cancer Research, Eli Lilly (United States), Sarah Cannon Research Institute, Pfizer (United States), Genentech, Wayne State University, Utrecht University, Mario Negri Institute for Pharmacological Research, Queen's University, Western General Hospital, Maastricht University Medical Centre, Queen Elizabeth II Health Sciences Centre, Beatson West of Scotland Cancer Centre, Royal Victoria Infirmary, Peter MacCallum Cancer Centre, Poole Hospital, Mount Vernon Hospital, Churchill Hospital, Cancer Research UK, St James's University Hospital, Newcastle upon Tyne Hospitals NHS Foundation Trust, Institut Jules Bordet, Institut Gustave Roussy, Freeman Hospital, Slotervaartziekenhuis, Charing Cross Hospital, Wellcome Sanger Institute, John Radcliffe Hospital, University of Manchester, The Netherlands Cancer Institute, Institute of Oncology Ljubljana, Maastricht University, Humboldt-Universität zu Berlin, University of Oxford, Institute of Cancer Research, Centre Georges François Leclerc, Ospedale San Giovanni Bellinzona, Fundación Instituto Valenciano de Oncología, Institut Català d'Oncologia, Queen Elizabeth Hospital, Mount Vernon Cancer Centre, Boehringer Ingelheim (United Kingdom), PharmaMar (Spain), Royal Marsden Hospital, Asklepios Klinik St. Georg, European Organisation for Research and Treatment of Cancer, Newcastle upon Tyne Hospital, Vall d'Hebron Hospital Universitari, The Christie Hospital, The Christie NHS Foundation Trust, University of Colorado Cancer Center, Poole Hospital NHS Foundation Trust, National Cancer Institute, Cancer Research UK Scotland Institute, National Cancer Center Hospital East, Wolters Kluwer Health, Velindre Cancer Centre, Addenbrooke's Hospital, NanoCarrier (Japan), Instituto Nazionale Tumori Regina Elena, National Cancer Center Hospital, University College London, University of Glasgow, Penn State Milton S. Hershey Medical Center, Newcastle University, Kindai University, Stanford University
OpenAlex ID: A5047677453
1989 · A H Calvert, D R Newell, et al. · Journal of Clinical Oncology · 1,869
1988 · A.H. Calvert, A. Horwich, et al. · The Lancet · 1,183
2000 · HS Friedman, T Kerby, et al. · PubMed · 726
2004 · C. R. Calabrese, R. Almassy, et al. · JNCI Journal of the National Cancer Institute · 486
1982 · A. H. Calvert, S. J. Harland, et al. · Cancer Chemotherapy and Pharmacology · 484
2006 · Yan Zhao, Huw D. Thomas, et al. · Cancer Research · 445
2002 · G.J Peters, H.H.J Backus, et al. · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · 420
2008 · Jann N. Sarkaria, Gaspar J. Kitange, et al. · Clinical Cancer Research · 373
2010 · Timothy A. Yap, Laura Vidal, et al. · Journal of Clinical Oncology · 346
1995 · N M Bleehen, E S Newlands, et al. · Journal of Clinical Oncology · 282
2007 · Ruth Plummer, Gerhardt Attard, et al. · Clinical Cancer Research · 247
1997 · M. Bower, E. S. Newlands, et al. · Cancer Chemotherapy and Pharmacology · 221
1987 · P Selby, S Hobbs, et al. · British Journal of Cancer · 204
1993 · D.G. Allen, J. Baak, et al. · Annals of Oncology · 184
Works count: 448
Citation count: 20,530
H-index: 65
I10-index: 205
Year
Topic
Type